Ellington Management Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Ellington Management Group’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,400	Closed	-$483K	–	913
2018 Q1	$483K	Buy	7,400 +5,067	+217%	+$359K	0.03%	417
2017 Q4	$170K	Sell	2,333 -1,845	-44%	-$153K	0.03%	512
2017 Q3	$383K	Buy	+4,178	New	+$320K	0.07%	303
2017 Q2	–	Sell	-1,022	Closed	-$222K	–	944
2017 Q1	$222K	Buy	+1,022	New	+$146K	0.01%	549
2016 Q1	–	Sell	-912	Closed	-$299K	–	735
2015 Q4	$299K	Buy	+912	New	+$297K	0.11%	280
2015 Q2	–	Sell	-1,233	Closed	-$607K	–	921
2015 Q1	$607K	Buy	+1,233	New	+$478K	0.13%	224
2014 Q2	–	Sell	-1,689	Closed	-$432K	–	694
2014 Q1	$432K	Buy	+1,689	New	+$516K	0.13%	248

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ellington Management Group's LUMO Position: Q2 2018 in Review

Ellington Management Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 7,400 shares — an estimated $483K sold.

Ellington Management Group first reported a position in LUMO in Q1 2014 and held it in 7 quarters. The position peaked at $607K in Q1 2015. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Ellington Management Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Ellington Management Group sold 7,400 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $483K.
Ellington Management Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2014 and held it in 7 quarters.
Ellington Management Group's Lumos Pharma, Inc. Common Stock position peaked at $607K in Q1 2015.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.